장용성 소프트젤 시장 규모, 점유율, 성장 분석 : 제품 유형별, 원재료별, 유통 채널별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Enteric Softgel Market Size, Share, and Growth Analysis, By Product Type (Gelatin Softgel Capsules, Vegetarian Softgel Capsules), By Raw Material, By Distribution Channel, By Application, By End User, By Region - Industry Forecast 2025-2032
세계의 장용성 소프트젤 시장 규모는 2023년에 24억 달러로 평가되며, 2024년 25억 달러에서 2032년에는 34억 5,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 4.1%로 성장할 전망입니다.
반고체 및 액체 의약품용 젤라틴 기반 코팅을 특징으로 하는 장용성 소프트젤 캡슐 시장은 예방 의학의 이점에 대한 소비자의 인식 증가, 노인 인구 증가, 만성질환 및 영양 결핍의 확산으로 인해 크게 성장할 것으로 예상됩니다. 건강에 대한 인식이 높아짐에 따라 건강보조식품에 대한 수용도가 높아져 수요를 더욱 촉진하고 있습니다. 주목할 만한 것은 채식주의 소비자를 위한 혁신적인 비젤라틴 제품이 등장하고 있으며, 전분 및 식물성 원료를 사용하여 시장의 매력을 높이고 있다는 점입니다. 또한 E-Commerce 플랫폼의 확대와 캡슐의 생체 이용률 향상을 위한 주요 기업의 R&D 투자 활성화는 시장 역학에 긍정적인 영향을 미칠 것으로 보입니다. 물 없이도 섭취할 수 있는 츄어블 소프트젤의 선택은 향후 수년간 시장 전망을 높일 것으로 예상됩니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 시장 에코시스템
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 규제 상황
- 사례 연구
- 기술의 진보
장용성 소프트젤 시장 규모 : 제품 유형별 & CAGR(2025-2032)
- 시장 개요
- 젤라틴 소프트젤 캡슐
- 채식주의자 소프트젤 캡슐
장용성 소프트젤 시장 규모 : 원재료별 & CAGR(2025-2032)
- 시장 개요
- A형 젤라틴(돈피)
- B형 젤라틴(동물 뼈와 가죽)
- 어골 젤라틴
- 셀룰로오스 유도체
- 전분질 재료
장용성 소프트젤 시장 규모 : 유통 채널별 & CAGR(2025-2032)
- 시장 개요
- 슈퍼마켓과 하이퍼마켓
- 약국·드러그스토어
- 온라인 프로바이더
장용성 소프트젤 시장 규모 : 용도별 & CAGR(2025-2032)
- 시장 개요
- 제산제 및 정장제
- 항염증약
- 항생제 및 항균제
- 기침과 감기 대책
- 건강보조제
- 비타민과 식이보충제
- 기타 치료 용도
장용성 소프트젤 시장 규모 : 최종사용자별 & CAGR(2025-2032)
- 시장 개요
- 제약회사
- 뉴트라슈티컬 회사
- 화장품 회사
- 식품 산업
장용성 소프트젤 시장 규모 : 지역별 & CAGR(2025-2032)
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 개요
- 기업의 상세
- 제품 포트폴리오 분석
- 기업의 부문별 점유율 분석
- 매출의 전년대비 비교(2022-2024)
주요 기업 개요
- BASF SE(Germany)
- Colorcon Inc.(United States)
- Fuji Capsule Co., Ltd.(Japan)
- Lonza Group AG(Switzerland)
- Now Health Group Inc.(United States)
- ProCaps Group(Luxembourg)
- Super Spectrim(United States)
- Thermo Fisher Scientific Inc.(United States)
- Key Developments
- Sirio Pharma Co., Ltd.(China)
- Soft Gel Technologies, Inc.(United States)
- EuroCaps Ltd.(United Kingdom)
- Geltec Pvt. Ltd.(India)
- Captek Softgel International, Inc.(United States)
- Elnova Pharma(Canada)
- Best Formulations(United States)
- Pharmavite LLC(United States)
- Robinson Pharma, Inc.(United States)
결론과 제안
KSA
Global Enteric Softgel Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.5 billion in 2024 to USD 3.45 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).
The market for enteric softgel capsules, which feature gelatin-based coatings for semi-solid and liquid medications, is poised for significant growth, driven by increasing consumer awareness of preventive medicine benefits, a rising geriatric population, and the prevalence of chronic and nutrient deficiency diseases. As health consciousness grows, so does the acceptance of dietary supplements, further fueling demand. Notably, innovative non-gelatin variants catering to vegan consumers are emerging, utilizing starch and plant-based sources to enhance market appeal. Additionally, the expansion of e-commerce platforms and heightened R&D investments by major players aimed at improving capsule bioavailability are set to positively influence market dynamics. Chewable softgel options that require no water to consume are anticipated to boost market prospects in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enteric Softgel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Enteric Softgel Market Segments Analysis
Global Enteric Softgel Market is segmented by Product Type, Raw Material, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Gelatin Softgel Capsules and Vegetarian Softgel Capsules. Based on Raw Material, the market is segmented into Type-A Gelatin (Pork Skin), Type-B Gelatin (Animal Bones and Skin), Fish Bone Gelatin, Cellulose Derivatives and Starch Material. Based on Distribution Channel, the market is segmented into Supermarket and Hypermarket, Pharmacy and Drug store and Online Provider. Based on Application, the market is segmented into Antacid and Antiflatulent Preparations, Anti-inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplements, Vitamin and Dietary Supplements and Other Therapeutic Applications. Based on End User, the market is segmented into Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Food Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Enteric Softgel Market
The global enteric softgel market is primarily driven by a surge in investments aimed at enhancing the bioavailability of these capsules. Notably, leading companies are ramping up production to satisfy the growing demand for health-focused nutritional supplements. For instance, Catalent Pharma Solutions, a prominent American player, recently announced plans to invest over USD 5 million in a new drug development center located in Somerset, New Jersey. This investment is expected to bolster the company's capabilities in capsule coating technology, thereby strengthening its position within the enteric softgel market. As advanced manufacturing techniques are developed and major players focus on improving efficiency, the market is set to witness increased productivity and reduced complexity in drug development processes.
Restraints in the Global Enteric Softgel Market
The global enteric softgel market faces significant challenges related to the stability and shelf-life of these capsules. Consumers often encounter issues when storing enteric softgels for more than six months, leading to concerns about their efficacy. Moreover, the inherent dynamic nature of these capsules complicates efforts for manufacturers to enhance both their shelf-life and chemical stability. As a result, this limitation can hinder widespread adoption and consumer confidence in enteric softgel products, posing a notable restraint on market growth and innovation. Addressing these stability issues will be crucial for advancing the market potential of enteric softgel capsules.
Market Trends of the Global Enteric Softgel Market
The Global Enteric Softgel market is experiencing a notable shift towards vegan alternatives, driven by the rising trend of veganism and growing consumer awareness regarding animal welfare and health impacts associated with traditional gelatin-based capsules. As more consumers adopt vegetarian and vegan lifestyles, demand for plant-based enteric softgel options is expected to increase significantly. This paradigm shift is compelling manufacturers to innovate and reformulate products, utilizing ingredients such as hydroxypropyl methylcellulose and other plant-derived substances. Market dynamics are thus evolving, with a focus on sustainability and health-conscious choices poised to define the future landscape of the enteric softgel industry.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Landscape
- Case Studies
- Technological Advancement
Global Enteric Softgel Market Size by Product Type & CAGR (2025-2032)
- Market Overview
- Gelatin Softgel Capsules
- Vegetarian Softgel Capsules
Global Enteric Softgel Market Size by Raw Material & CAGR (2025-2032)
- Market Overview
- Type-A Gelatin (Pork Skin)
- Type-B Gelatin (Animal Bones and Skin)
- Fish Bone Gelatin
- Cellulose Derivatives
- Starch Material
Global Enteric Softgel Market Size by Distribution Channel & CAGR (2025-2032)
- Market Overview
- Supermarket and Hypermarket
- Pharmacy and Drug store
- Online Provider
Global Enteric Softgel Market Size by Application & CAGR (2025-2032)
- Market Overview
- Antacid and Antiflatulent Preparations
- Anti-inflammatory Drugs
- Antibiotic and Antibacterial Drugs
- Cough and Cold Preparations
- Health Supplements
- Vitamin and Dietary Supplements
- Other Therapeutic Applications
Global Enteric Softgel Market Size by End User & CAGR (2025-2032)
- Market Overview
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Food Industry
Global Enteric Softgel Market Size & CAGR (2025-2032)
- North America (Product Type, Raw Material, Distribution Channel, Application, End User)
- Europe (Product Type, Raw Material, Distribution Channel, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Raw Material, Distribution Channel, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Raw Material, Distribution Channel, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Raw Material, Distribution Channel, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Colorcon Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fuji Capsule Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Now Health Group Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ProCaps Group (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Super Spectrim (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sirio Pharma Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Soft Gel Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EuroCaps Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Geltec Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Captek Softgel International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elnova Pharma (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Best Formulations (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pharmavite LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Robinson Pharma, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
